Table 1: Demographics.
|
N |
12 |
|
% Female |
92% |
|
Age (mean, years) |
61.6 +/-12.2 |
|
Race |
|
|
White n (%) |
10 (83%) |
|
Hispanic/Latino n (%) |
0 |
|
Asian n (%) |
2 (17%) |
|
Black/African American n (%) |
0 |
|
BMI (kg/m2) |
21.6 +/-3.3 |
|
Tobacco use history |
|
|
Never smoker n (%) |
10 (83%) |
|
Former smoker n (%) |
2 (17%) |
|
Average pack years (years) |
15 |
|
Co-morbidities |
|
|
Asthma n (%) |
3 (25%) |
|
COPD n (%) |
0 |
|
Immunocompromised n (%) |
1 (8.3%) |
|
Rheumatologic disease n (%) |
1 (8.3%) |
|
GERD n (%) |
7 (58%) |
|
Diabetes n (%) |
0 |
|
HTN n (%) |
3 (25%) |
|
Pre-operative PFTs |
|
|
FEV1/FVC% predicted |
74% |
|
FEV1 L (% predicted) |
2.22 L (83.4 %) |
|
FVC L (% predicted) |
2.98 L (90.1%) |
|
DLCO % predicted |
81% |
|
Indication for surgery |
|
|
Failure of medical therapy n (%) |
3 (25%) |
|
Cavitary disease n (%) |
7 (58%) |
|
Hemoptysis n (%) |
2 (16%) |
|
NTM species |
|
|
MAI n (%) |
12 (100%) |
|
M abscessus n (%) |
0 |
|
M xenopi n (%) |
0 |
NTM-LD: Non-tuberculous mycobacterial lung disease; BMI: Body mass index; COPD: Chronic obstructive pulmonary disease; GERD: Gastroesophageal reflux disease; HTN: Hypertension; FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity; DLCO: Diffusing capacity of the lungs for carbon monoxide; NTM: Non-tuberculous mycobacteria; MAI: Mycobacterium avium intracellulare; M abscessus: Mycobacterium abscessus; M xenopi: Mycobacterium xenopi